Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bimatoprost (lashes) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Prescription topical. Bimatoprost 0.03% is applied once daily as a thin line to the skin of the UPPER eyelid margin at the lash base (not to the lower lid, and avoid getting it in the eye), using a fresh applicator per eye. Continuous use is needed to maintain results. Use under a clinician, especially if you have glaucoma or take prostaglandin eye drops. There is no oral or systemic use. This library does not provide an ingestion protocol.
evening
Bimatoprost 0.03% solution (Latisse) with single-use applicators, under a clinician
Topical cosmetic only. L-ascorbic acid serums are typically 10-20% (often near pH 3 for absorption); stable derivatives are used at varying percentages. Apply a few drops to clean, dry skin, usually in the morning under sunscreen (its antioxidant action complements SPF). There is no oral, injectable, or systemic dose in this cosmetic context. This library does not provide an ingestion protocol.
morning
Leave-on topical serum (10-20% L-ascorbic acid) or a stable vitamin C derivative
Throughout
8-16 weeks
2-6 months after stopping
Weeks to months
Throughout
8-12 weeks
8-24 weeks
Throughout
Long-term safety and efficacy of bimatoprost solution 0.03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
Br J Dermatol (2015) · Rct
1-year double-masked RCT: composite primary endpoint (Global Eyelash Assessment + satisfaction) met for bimatoprost vs vehicle in idiopathic (40.2% vs 6.8%) and post-chemotherapy (37.5% vs 18.2%) hypotrichosis
Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
Aesthetic Plast Surg (2014) · Rct · n=209
Two double-masked vehicle-controlled RCTs (n=209: 173 idiopathic, 36 chemotherapy-induced) in Japanese subjects
The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis.
Front Med (Lausanne) (2023) · Meta analysis
Meta-analysis of six placebo-controlled RCTs of topical prostaglandin analogs (incl. bimatoprost) for hair growth (lashes, brows, scalp)
Use of topical ascorbic acid and its effects on photodamaged skin topography.
Arch Otolaryngol Head Neck Surg (1999) · Rct · n=19
Split-face, randomized, double-blind, vehicle-controlled trial: active L-ascorbic acid serum vs vehicle daily for 3 months in mild-to-moderate facial photodamage
Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo.
Exp Dermatol (2003) · Rct
6-month double-blind randomized trial comparing 5% vitamin C cream vs its excipient on photoaged skin of the low-neck and arms
Efficacy of topical vitamin C in melasma and photoaging: A systematic review.
J Cosmet Dermatol (2023) · Systematic review
Systematic review of prospective RCTs of topical vitamin C in melasma or photodamage: 7 publications, 139 total volunteers
Bimatoprost (lashes) has a higher evidence score (8/10 vs 6/10) and wins in 2 of 3 categories.
No known interactions between Bimatoprost (lashes) and Vitamin C (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.